Search results :

Ipratropium bromide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: R01AX03, R03BB01

Side effects

Options: Show MedDRA Preferred Terms,   display all 30 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
COPD exacerbation 8% - 23% 13% x x
Bronchitis 2.9% - 24.5% 6% x x x x x x x x x x x
Bad taste 5.1% - 16% x x
Upper respiratory tract infection 1.4% - 34% 16% x x x x x x x x x x x x x x
Dyspnoea 1.8% - 13.2% 4% x x x x x x x x x x x
Urinary tract infection 2% - 10% 1% x x x x x x x x x
Flatulence common x x
Cough postmarketing — 0% - 8% 6% x x x x x x x x x x x x x x x x x x x x
Epistaxis 0.3% - 9% x x x x x x
Infection 1.4% - 9.8% x
Headache common, 0% - 9.8% 8% x x x x x x x x x x x x x x x x x x x x
Pharyngitis 0% - 8.1% x x x x x x x x x x x x x x x
Influenza-like symptoms 0.5% - 8% 2% x x x x x x x x x
Tremor 0.9% - 31.9% x x x x x x x x
Pain postmarketing, 0.9% - 4.1% x x x x x x x x x x x x x x x
Sinusitis postmarketing, 1% - 14% 3% x x x x x x x x x x
Nasal dryness 0% - 5.1% x x x x x x
Back pain 1.9% - 7% 2% x x x x x x x x x
Rhinitis 2% - 6% 4% x x x x x x x x x x x x x x
Bronchospasm postmarketing — 2.3% - 5.4% x x x x x x x
Dizziness common, 0% - 3.9% 2% x x x x x x x x x x x x x x x x x x x x
Nausea postmarketing — 0% - 4.1% 2% x x x x x x x x x x x x x x x x x x x
Chest pain 0.7% - 4.2% x x x x x x x x x
Dry mouth common, 0% - 28.1% 2% x x x x x x x x x x x x x x x x x x x
Nervousness 0.5% - 4.7% x x x x x x x x
Dysgeusia 1.2% - 3.7% x x x x x x x x x x x
Hypertension 0.9% - 1.9% x x x x x x
Hypertension worsened 0.9% - 1.9% x x x x x
Sputum increased 1.4% - 3.4% x x x x x
Nasal irritation 0% - 2% x x x x
Dyspepsia common, 0% - 5% 1% x x x x x x x
Arthritis 0.5% - 1.4% x x x x x x
Constipation postmarketing — 0% - 1.4% x x x x x x x x x x x x x x x x x
Sweating 0.9% x x
Insomnia 0.2% - 1.9% x x x x x x x x
Bronchospasm aggravated 0.7% - 1% x x
Abnormal vision 0.5% - 1.2% x x
Palpitations postmarketing — 0.5% - 2.1% x x x x x x x x x x x x x x x x x x
Dysuria 0.2% - 1% x x
Pollakiuria 0.2% - 1% x x
Dysphonia 0.2% - 1% x x x
Flushing 0% - 1.1% x x
Vomiting postmarketing — 2.1% x x x x x x x x x x x
Eye pain postmarketing — 0.9% x x x x x x x x x x x x x x x x
Dry throat uncommon x x x x
Vision blurred uncommon x x x x x x x x x x
Diarrhoea postmarketing — 0.5% - 1.8% x x x x x x x x x x
Numbness in leg 0% - 1% x x
Nasal congestion 0% - 1.1% x x x
Anaphylactic shock postmarketing, uncommon x x x x x x x x x x x x x x x x
Angioedema postmarketing, uncommon x x x x x x x x x x x x x x x x x
Asthma postmarketing x
Atrial fibrillation postmarketing, rare x x x x x x x
Corneal oedema postmarketing, uncommon x x x x x x
Oedema postmarketing x x x
Rash postmarketing, uncommon x x x x x x x x x x x x x x x x x x x
Glaucoma postmarketing, uncommon x x
Angle closure glaucoma postmarketing x x x x x x x x x x x
Hypersensitivity postmarketing, uncommon x x x x
Intestinal obstruction postmarketing x x x
Laryngospasm postmarketing, uncommon x x x x x x x x x x x x x x x x x
Chronic obstructive pulmonary disease postmarketing x x
Mydriasis postmarketing, uncommon x x x x x x x x x x x x x x
Pruritus postmarketing, uncommon x x x x x x x x
Stomatitis postmarketing, uncommon x x x x x x
Tachycardia postmarketing, rare x x x x x x x x x x x x x x x x x x
Supraventricular tachycardia postmarketing, uncommon x x x x x x x x x
Urticaria postmarketing, rare x x x x x x x x x x x x x x
Wheezing postmarketing x x x x
Urinary retention postmarketing — 1.4% x x x x x x x x x x x x x x x x x
Accommodation disorder postmarketing, rare x x x x x x
Intraocular pressure increased postmarketing, uncommon x x x x x x x x x x
Eye irritation postmarketing x x x x
Pharyngeal oedema postmarketing, uncommon x x x x x x
Oedema mouth postmarketing, uncommon x x x x x x
Bronchospasm paradoxical postmarketing, uncommon x x x x x
Halo vision postmarketing, uncommon x x x x x x
Distress gastrointestinal postmarketing x x x x
Throat irritation postmarketing, common x x x x x x x
Generalized urticaria postmarketing x x x
Gastrointestinal motility disorder postmarketing, common x x x x x
Nasal discomfort postmarketing x x x
Conjunctival hyperaemia postmarketing, uncommon x x x x x
Abdominal pain x
Congenital anomaly x
Breast feeding x
Cardiovascular disorder x x x x x x
Conjunctivitis x x x x x x
Dysphagia x
Eye disorder x x x
Fatigue x x x
Gastrointestinal disorder x x x
Cardiac disorder x x x
Haemorrhage x x x
Hoarseness x x x x x
Type I hypersensitivity x x
Hypoaesthesia x x
Hypotension x x
Immune system disorder x x x
Inflammation x
Lung disorder x
Mediastinal disorder x x x
Nasal polyps x x
Nervous system disorder x x x
Paraesthesia x x
Neuropathy peripheral x x x
Pregnancy x
Salivary hypersecretion x x
Status asthmaticus x x
Swelling x
Thirst x x
Tinnitus x x
Ulcer x x
Urinary tract disorder x x x x x x
Disorder sight x
Bronchoconstriction x
Tongue oedema x
Acute angle-closure glaucoma x x
Unspecified disorder of skin and subcutaneous tissue x x x
Myalgia x x
Taste bitter x x x
Swollen tongue x
Heart rate irregular x
Acute glaucoma x x
Prostatomegaly x
Nasal oedema x x
Nasal burning x x x x
Emotional distress
Nasal itching x x
Local reaction x
Oropharyngeal swelling x x x
Foetal damage x
Glaucoma both eyes x x
Nasal mucus blood tinged x
Flu symptoms x x
Somnolence x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

IPRATROPIUM

Side effects:22
Source:FDA Structured Product Label

IPRATROPIUM

Side effects:22
Source:FDA Structured Product Label

IPRATROPIUM

Side effects:34
Source:FDA Structured Product Label

IPRATROPIUM

Side effects:34
Source:FDA Structured Product Label

IPRATROPIUM

Side effects:35
Source:FDA Structured Product Label

IPRATROPIUM

Side effects:35
Source:FDA Structured Product Label

Ipratropium cation

Side effects:35
Source:FDA Structured Product Label

Ipratropium

Side effects:36
Source:FDA Structured Product Label

ipratropium bromide HFA / Atrovent HFA

Side effects:37
Source:FDA

IPRATROPIUM BROMIDE / ATROVENT HFA

Side effects:40
Source:Health Canada

IPRATROPIUM

Side effects:43
Source:FDA Structured Product Label

Ipratropium bromide / ATROVENT Metered Aerosol (CFC-free)

Side effects:47
Source:medicines.org.au

DESCRIPTION / ATROVENT NASAL and ATROVENT NASAL FORTE

Side effects:50
Source:medicines.org.au

IPRATROPIUM

Side effects:53
Source:FDA Structured Product Label

IPRATROPIUM

Side effects:53
Source:FDA Structured Product Label

IPRATROPIUM

Side effects:55
Source:FDA Structured Product Label

IPRATROPIUM BROMIDE / PMS-IPRATROPIUM (1ML UNIT DOSE)

Side effects:56
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label